In the BioHarmony Drug Report Database
Mustargen, Valchlor, Ledaga (mechlorethamine) is a small molecule pharmaceutical. Mechlorethamine was first approved as Mustargen on 1982-01-01. It is used to treat hodgkin disease, malignant pleural effusion, mycosis fungoides, and neoplasm metastasis in the USA. It has been approved in Europe to treat mycosis fungoides. Valchlor’s patents are valid until 2029-07-08 (FDA).
Image (chem structure or protein)